重症COVID-19患者急性心肌损伤发生率及其与左右心室收缩功能障碍的关系
该研究连续纳入2020年3月19日至12月31日期间在Linköping大学医院ICU收治的74例COVID-19成人患者,每日检测高敏肌钙蛋白T(hsTnT)最长14天,入ICU 72小时内行经胸超声心动图。结果显示59%的患者入ICU时hsTnT升高,82%在入ICU后8(3-13)天出现急性心肌损伤(AMInj)峰值。AMInj与30天死亡率无显著关联,但与有创机械通气时间延长(10(3-13)天 vs 5天(0-9),p=0.001)及ICU住院时间延长(19.5(11-28)天 vs 7天(5-13),p=0.015)相关;校正SAPS-3和入ICU SOFA评分后,仅机械通气时间仍显著(p=0.030)。左心室和右心室功能障碍发生率分别为28%和22%,仅二尖瓣环和三尖瓣环收缩期位移与AMInj相关,超声参数与临床结局无关。
要点
- 在74例连续入ICU的COVID-19成人患者中,82%发生急性心肌损伤(hsTnT>14 ng/L且绝对变化>20%),峰值在入ICU后8(3-13)天。
- 急性心肌损伤与有创机械通气时间延长相关(10(3-13)天 vs 5天(0-9),p=0.001),校正SAPS-3和SOFA后仍显著(p=0.030)。
- 急性心肌损伤与ICU住院时间延长相关(19.5(11-28)天 vs 7天(5-13),p=0.015),但与30天死亡率无显著关联。
- 左心室和右心室收缩功能障碍发生率分别为28%和22%,仅二尖瓣环和三尖瓣环收缩期位移与急性心肌损伤相关。
- 超声心动图参数与临床结局无显著关联。
适用人群与场景
- 2020年3月19日至12月31日在Linköping大学医院ICU连续收治的74例COVID-19成人患者(≥18岁)。
诊断标准与关键阈值
- 急性心肌损伤定义:高敏肌钙蛋白T(hsTnT)>14 ng/L且绝对变化>20%,伴或不伴缺血症状。
- 左心室和右心室收缩功能障碍定义:符合共识指南规定的至少2项收缩功能指标异常。
研究设计与关键结果
- 研究类型:单中心连续病例研究;样本量74例;人群:ICU收治的COVID-19成人患者;干预:每日检测hsTnT最长14天,入ICU 72小时内行经胸超声心动图。
- 59%的患者入ICU时hsTnT升高,82%发生急性心肌损伤,峰值在入ICU后8(3-13)天。
- 急性心肌损伤与30天死亡率无显著关联,但与有创机械通气时间延长相关(10(3-13)天 vs 5天(0-9),p=0.001),与ICU住院时间延长相关(19.5(11-28)天 vs 7天(5-13),p=0.015)。
- 校正SAPS-3和入ICU SOFA评分后,急性心肌损伤仅对机械通气时间的影响显著(p=0.030)。
- 左心室和右心室功能障碍发生率分别为28%和22%;仅二尖瓣环和三尖瓣环收缩期位移与急性心肌损伤相关。
- 超声心动图参数与临床结局无显著关联。
证据类型、等级与局限
- 证据类型:单中心连续病例研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,重症COVID-19患者急性心肌损伤常见,超过80%在入ICU后发生,而左、右心室功能障碍各约占四分之一。
- 作者认为,急性心肌损伤与机械通气需求增加和ICU住院时间延长相关,但急性心肌损伤和心室功能障碍均与死亡率无显著关联。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Previous studies have found an increase in cardiac troponins (cTns) and echocardiographic abnormalities in patients with COVID-19 and reported their association with poor clinical outcomes. Whether acute injury occurs during the course of critical care and if it is associated with cardiac function is unknown. The purpose of this study was to document the incidence of acute myocardial injury (AMInj) and echocardiographically defined left ventricular (LV) and right ventricular (RV) systolic dysfunction in consecutive patients admitted to an intensive care unit (ICU) for COVID-19. The relationship between AMInj and echocardiographic abnormalities during the first 14 days of ICU admission was studied. Finally, the association between echocardiographic findings, AMInj and clinical outcome was evaluated.
METHODS: Seventy-four consecutive patients (≥18 years) admitted to the ICU at Linköping University Hospital between 19 Mar 2020 and 31 Dec 2020 for COVID-19 were included. High-sensitivity troponin-T (hsTnT) was measured daily for up to 14 days. Transthoracic echocardiography was conducted within 72 h of ICU admission. Acute myocardial injury was defined as an increased hsTnT > 14ng/l and a > 20% absolute change with or without ischaemic symptoms. LV and RV systolic dysfunction was defined as at least 2 abnormal indicators of systolic function specified by consensus guidelines.
RESULTS: Increased hsTnT was observed in 59% of patients at ICU admission, and 82% developed AMInj with peak levels at 8 (3-13) days after ICU admission. AMInj was not statistically significantly associated with 30-day mortality but was associated with an increased duration of invasive mechanical ventilation (10 (3-13) vs. 5 days (0-9), p=0.001) as well as ICU length of stay (LOS) (19.5 (11-28) vs. 7 days (5-13), p=0.015). After adjustment for SAPS-3 and admission SOFA score, the effect of AMInj was significant only for the duration of mechanical ventilation (p=0.030). The incidence of LV and RV dysfunction was 28% and 22%, respectively. Only indices of LV and RV longitudinal contractility (mitral and tricuspid annular plane systolic excursion) were associated with AMInj. Echocardiographic parameters were not associated with clinical outcome.
CONCLUSIONS: Myocardial injury is common in critically ill patients with COVID-19, with AMInj developing in more than 80% after ICU admission. In contrast, LV and RV dysfunction occurred in approximately one-quarter of patients. AMInj was associated with an increased need for mechanical ventilation and ICU LOS but neither AMInj nor ventricular dysfunction was significantly associated with mortality.
参考来源
- Jansson S, Blixt PJ, Didriksson H, et al. Incidence of acute myocardial injury and its association with left and right ventricular systolic dysfunction in critically ill COVID-19 patients. Ann Intensive Care. 2022. PMID: 35727386. doi:10.1186/s13613-022-01030-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。